Donaldson Company, Inc. (NYSE: DCI)

Quick Facts / Company Snapshot

• Company Name: Donaldson Company, Inc.
• Ticker Symbol: DCI
• Stock Exchange: New York Stock Exchange
• Year Founded: 1915
• Headquarters: 1400 West 94th Street, Bloomington, Minnesota 55431
• Total Revenue (Fiscal 2025): $3,690.9 million
• Net Earnings (Fiscal 2025): $367.0 million
• Diluted Earnings Per Share (Fiscal 2025): $3.05
• Gross Margin: 34.8%
• Operating Margin: 13.4%
• Total Assets: $2,977.2 million
• Total Employees: Approximately 15,000
• Global Footprint: Over 150 locations on six continents
• Manufacturing & Distribution Centers: 77 locations globally
• Largest Revenue Segment: Mobile Solutions ($2,291.0 million)
• Largest Geographic Market: United States and Canada (44.2% of sales)
• Research & Development Spend: $87.8 million (2.4% of net sales)
• Capital Expenditures: $77 million
• Dividend Track Record: Increased for 30 consecutive years
• Key Strategic Model: Create-Connect-Replace-Service

Company Overview

Donaldson Company, Inc. is a global leader specializing in technology-led filtration products and solutions. The enterprise serves a diverse array of industries and advanced markets, partnering with clients ranging from small business owners to research and development organizations and the world’s largest original equipment manufacturer brands. The corporate framework is built upon decades of application expertise, continuous capital allocation toward research, and state-of-the-art technologies designed to solve complex filtration challenges.

The operational structure spans six continents, supported by a skilled workforce of approximately 15,000 employees. Over half of these employees, representing 58% of the global headcount, are dedicated exclusively to production-related roles. The organizational focus prioritizes stringent technical and performance requirements, ensuring reliability and delivering a strong value proposition through advanced solutions and comprehensive services.

• Total Revenue: The enterprise generated $3,690.9 million in total sales for fiscal 2025, marking steady top-line expansion.
• Adjusted Operating Margin: The organization achieved a record adjusted operating margin of 15.7%, showcasing operational leverage.
• Global Locations: The footprint includes over 150 administrative, technical, and commercial locations worldwide.
• Manufacturing Nodes: The global supply chain operates through 77 specialized manufacturing and distribution centers designed for regional responsiveness.

The overarching purpose of the enterprise is to advance filtration for a cleaner world, addressing needs today and anticipating requirements for tomorrow. This mission is underpinned by a robust business model heavily weighted toward aftermarket operations. This model consistently generates recurring revenue, effectively offsetting the cyclical pressures typically associated with new heavy equipment sales.

Business Segments

The organizational architecture is divided into three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences. Each segment is strategically tailored to address specific market demands, regulatory environments, and customer profiles.

Mobile Solutions

Revenue: $2,291.0 million | % of Total Revenue: 62.1%

The Mobile Solutions segment represents the largest revenue and profit generator for the enterprise. It is organized around a combination of specific customers and products, fundamentally consisting of the Aftermarket, Off-Road, and On-Road business units. This segment focuses heavily on replacement filters for both air and liquid filtration applications, alongside filtration housings utilized in new equipment production and advanced exhaust and emissions systems.

The operational scope encompasses highly engineered air filtration systems, fuel, lube, and hydraulic systems, as well as emissions systems, sensors, indicators, and advanced monitoring technologies. The primary customer base includes original equipment manufacturers in the construction, mining, agriculture, and transportation end markets, along with independent distributors and expansive OEM dealer networks globally.

• Aftermarket Revenue: $1,820.9 million, representing 49.3% of total enterprise revenue. This unit experienced a $90.7 million increase, driven by solid market demand and strategic market share gains.
• Off-Road Revenue: $359.5 million, representing 9.7% of total enterprise revenue.
• On-Road Revenue: $110.6 million, representing 3.0% of total enterprise revenue.
• Pre-Tax Earnings: $417.6 million, representing a highly lucrative 18.2% margin on net segment sales.

Industrial Solutions

Revenue: $1,104.4 million | % of Total Revenue: 29.9%

The Industrial Solutions segment is strategically organized based on product type. It delivers a comprehensive product offering designed to cost-effectively enhance productivity and manufacturing efficiency globally. The segment operates through the Industrial Filtration Solutions and Aerospace and Defense business units. Sales channels are highly diversified, reaching customers through specialized distributors, direct-to-consumer models, and OEM partnerships in selected global markets.

The product portfolio includes industrial dust, fume, and mist collectors, compressed air and gas purification systems, and specialized hydraulic and lubricated rotating filtration applications. Additionally, the segment provides highly complex air inlet systems engineered for gas compression, power generation, and natural gas liquefaction industries operating in severe environments.

• Industrial Filtration Solutions Revenue: $914.2 million, representing 24.8% of total enterprise revenue. Growth was heavily supported by persistent strength in both new equipment installations and replacement part sales.
• Aerospace and Defense Revenue: $190.2 million, representing 5.2% of total enterprise revenue. This specialized unit saw a $24.8 million increase due to ongoing strength in defense spending and commercial aviation recovery.
• Pre-Tax Earnings: $197.7 million, representing a robust 17.9% margin on net segment sales.

Life Sciences

Revenue: $295.5 million | % of Total Revenue: 8.0%

The Life Sciences segment is meticulously organized by end market. It caters to the high-growth Food and Beverage, Disk Drive, Vehicle Electrification and Medical Device, Microelectronics, and Bioprocessing Equipment and Consumables markets. The segment primarily targets large OEMs and end-users requiring highly specialized solutions for cell growth, viral separation, liquid purification, high purity filtration, and sensitive device protection.

Products within this segment include micro-environment gas and liquid filtration, bioprocessing equipment such as advanced bioreactors and fermenters, and recurring consumables like chromatography devices, reagents, and specialized membrane-based products. The segment also develops advanced air and gas filtration systems strictly required for semiconductor manufacturing cleanrooms, sensors, and modern electric vehicle battery systems.

• Total Segment Revenue: $295.5 million, reflecting a dynamic 9.8% year-over-year increase.
• Growth Drivers: The expansion was driven by strong market demand in the Disk Drive unit and notable, hard-won market share gains within the highly regulated Food and Beverage sector.
• Pre-Tax Earnings: $4.4 million, representing a 1.5% margin on net sales, marking a critical transition from prior developmental losses toward segment profitability.

History and Evolution

The enterprise was founded in 1915, initiating what has become a century-long trajectory of technological advancement in the industrial filtration sector. Over the decades, the organization has consistently evolved, shifting from localized agricultural operations in the American Midwest to a dominant global presence across multiple highly technical industries spanning six continents.

The evolution of the enterprise has been marked by a deliberate, patient strategy of technological expansion, massive intellectual property generation, and strictly targeted strategic acquisitions. The company holds a vast intellectual property portfolio comprising over 3,100 issued patents globally, reflecting a deep, institutional commitment to proprietary material science capabilities.

• Fiscal 2022 Strategic Expansion: The organization massively expanded its bioprocessing capabilities by acquiring Solaris Biotechnology S.r.l., an Italian designer of complex bioreactors and fermenters, and Purilogics LLC, an early-stage biotechnology firm focused on revolutionary membrane chromatography.
• Fiscal 2023 Strategic Expansion: The enterprise further scaled its Life Sciences segment by aggressively acquiring Isolere Bio, Inc., a developer of IsoTag™ reagents for viral vector purification, and Univercells Technologies, a Belgian producer of highly specialized single-use structured fixed-bed bioreactors.
• Infrastructure Growth: In October 2024, the enterprise launched its newest state-of-the-art distribution center in Olive Branch, Mississippi, significantly strengthening its logistical ability to meet surging demand in the high-margin North American aftermarket business.

Products and Services

The product portfolio is highly diversified and deeply technical, ensuring stability across varying macroeconomic cycles. The products are explicitly engineered to safeguard critical capital components, severely reduce maintenance downtime, and support strict sustainability metrics across global industries.

Air Filtration (Mobile Solutions)

Revenue: $1,365.6 million | % of Total Revenue: 37.0%

Air filtration systems are critical for protecting expensive engine components against abrasive wear caused by dust, silica, and environmental particles. These robust, heavy-duty systems are essential for agricultural tractors, construction excavators, mining machinery, and long-haul commercial vehicles. The organization sets the global industry standard with its highly engineered pleated cellulose filters and advanced, proprietary fine-fiber media technologies.

Industrial Air Filtration (Industrial Solutions)

Revenue: $516.7 million | % of Total Revenue: 14.0%

These complex systems are engineered to collect and neutralize dangerous dust, toxic fume, and chemical mist within enclosed manufacturing facilities. The expansive portfolio includes innovative cartridge-style and bag house collectors that support industrial customers throughout the complete equipment lifecycle. These solutions strictly serve the metals, mining, chemical processing, and rapidly emerging electric vehicle battery manufacturing markets.

Fuel & Lube (Mobile Solutions)

Revenue: $479.8 million | % of Total Revenue: 13.0%

Modern high-pressure fuel and lube systems are vital for removing microscopic contaminants that can critically destroy fuel injectors, valves, pumps, bearings, and actuators. The product line includes primary and secondary particulate filters, highly advanced coalescing fuel water separators, and all-in-one filtration systems designed to protect advanced machinery operating under dynamic, high-stress, and continuous conditions.

Hydraulic (Mobile Solutions)

Revenue: $332.2 million | % of Total Revenue: 9.0%

Hydraulic filtration solutions protect essential, high-pressure fluid power equipment. Applications range from basic suction strainers to severe high-pressure filters, return-line filters, and atmospheric breather filters. These products ensure superior contaminant retention, resulting in significantly cleaner oil, drastically reduced pump wear, and lower risks of catastrophic, unplanned downtime for multimillion-dollar heavy machinery.

Aerospace & Defense (Industrial Solutions)

Revenue: $184.5 million | % of Total Revenue: 5.0%

Designed specifically to protect mission-critical systems from catastrophic contamination, these highly specialized filtration products ensure the efficient and safe operation of fixed-wing aircraft, military helicopters, heavily armored ground defense vehicles, and naval vessels. The specialized portfolio covers engine intake, cabin air purification, avionics cooling air, fuel, high-temperature lubrication, and complex hydraulic flight systems.

Power Generation (Industrial Solutions)

Revenue: $184.5 million | % of Total Revenue: 5.0%

This heavily customized category provides leading global OEMs with massive, custom-engineered air intake systems for industrial gas turbines and heavy industrial compressors. The architectural-scale products are utilized in continuous-operation power plants, cross-country oil and gas delivery networks, and expansive petrochemical refining facilities. The lucrative aftermarket line features specialized cartridge filters, automated pulse cleaning systems, and critical structural retention hardware.

Industrial Gases (Industrial Solutions)

Revenue: $147.6 million | % of Total Revenue: 4.0%

Industrial gas solutions address challenging, high-purity purification objectives using premium filtration and advanced desiccant drying products. The precise category includes specialized dust collectors for industrial air compressors and highly efficient air/oil separators utilized within complex, automated manufacturing environments requiring strictly controlled air quality.

Emissions (Mobile Solutions)

Revenue: $110.7 million | % of Total Revenue: 3.0%

This environmentally critical category focuses on sound-reducing mufflers and highly complex emission control systems. Key products include diesel particulate filters, advanced exhaust fluid mixers, and catalytic reduction substrates. These products are mandated and strictly essential for reducing toxic emissions of particulate matter and greenhouse gases across highly regulated global transportation and construction markets.

Food & Beverage (Life Sciences)

Revenue: $110.7 million | % of Total Revenue: 3.0%

These highly specialized, sanitary solutions guarantee process and product integrity within global food and beverage manufacturing. Products include sterile liquid, sterile compressed air, and culinary steam filtration, alongside highly sophisticated automated bioreactors and tangential flow filtration equipment utilized in modern food science and alternative protein production.

Other Life Sciences (Life Sciences)

Revenue: $110.7 million | % of Total Revenue: 3.0%

This diverse, highly technical grouping includes Vehicle Electrification, Medical Devices, Microelectronics, and Bioprocessing components. Products range from pressure-equalizing battery and powertrain vents for electric vehicles to proprietary IsoTag™ chemical reagents and Purexa™ membrane chromatography, which are critically utilized in streamlining the massive manufacturing scale-up of advanced biopharmaceuticals and gene therapies.

Disk Drive (Life Sciences)

Revenue: $73.8 million | % of Total Revenue: 2.0%

Disk drive products utilize extremely advanced, proprietary absorbent materials to strictly control microscopic moisture and corrosive molecular contaminants in sealed microenvironments. These vital, specialized filters protect the delicate internal components necessary for global cloud computing servers, massive data storage centers, and high-speed streaming infrastructure.

Industrial Hydraulics (Industrial Solutions)

Revenue: $73.8 million | % of Total Revenue: 2.0%

Industrial hydraulic products solve severe, high-temperature contamination challenges strictly within harsh environments like steel mills, paper mills, heavy refineries, and high-cycle plastic molding facilities. These premium filtration products comprehensively protect vulnerable system components from abrasive wear metals, emulsified water, and destructive oxidation by-products, thereby extending the operational life of capital-intensive industrial equipment.

Brand Portfolio

The enterprise owns a vast, legally protected, and highly valuable portfolio of trademarks and proprietary technologies that are recognized globally for their elite performance and unquestionable reliability in severe conditions.

While specific financial revenue breakdowns per individual brand are not independently disclosed, these proprietary technologies are fully integrated into the physical products that directly drive the company’s multi-billion dollar, high-margin revenue stream.

• PowerCore®: This highly advanced, proprietary filtration technology drastically surpasses standard pleated cellulose filters in both particulate efficiency and physical compactness, making it the globally preferred, designed-in choice for major commercial OEM engines requiring smaller architectural footprints.
• Ultra-Web®: Delivering incredibly robust filtration in the absolute harshest global environments, this proprietary fine-fiber media is uniquely capable of withstanding the extreme high temperatures and severe, sustained humidity encountered by heavy industrial turbines and massive diesel engines operating in deserts or jungles.
• Ultra-Web® HD: A highly durable evolution of the core technology, this specialized media ensures mathematically consistent inter-fiber spacing at a microscopic level, strictly optimized for the extreme, fine dust environments heavily prevalent in aggressive surface mining operations.
• Synteq® XP: A highly advanced, multi-layered synthetic media offering significantly higher fuel system protection and component longevity under dynamic, high-vibration application conditions compared to any commercially available alternative media.
• Synteq® DRY: A leading, proprietary coalescing technology engineered specifically to physically remove significantly more emulsified water in real-world, high-stress operating conditions than traditional, outdated barrier filters.
• Duramax®: Globally renowned for achieving superior high-pressure performance in a convenient, rapid-change spin-on configuration, allowing it to easily replace more costly, harder-to-service legacy housing options in complex hydraulic systems.
• Alpha-Web™: A revolutionary, first-of-its-kind hydraulic filtration media featuring a specialized fine-fiber layer that dynamically traps and securely locks microscopic particles during frequent, aggressive flow-rate changes, completely transforming heavy equipment protection standards.
• iCue™: A proprietary, subscription-based Connected Filtration Technology that proactively monitors industrial dust collection equipment via cellular networks in real-time. This digital brand is designed to drastically reduce catastrophic unplanned downtime and optimize labor maintenance costs for plant managers.
• IsoTag™: Novel, strictly proprietary chemical reagents utilized exclusively for the rapid purification and highly streamlined commercial manufacturing of complex viral vectors used in advanced, multi-million dollar cell and gene therapies.
• scale-X™: A highly unique, patented single-use structured fixed-bed bioreactor designed specifically for the rapidly intensified, high-density production of viruses critically utilized in modern gene therapy and global viral vaccine manufacturing.
• NevoLine™: A complex automated upstream platform incorporating industry-standard filtration to provide highly integrated processing capabilities within a single, highly efficient, small-footprint manufacturing unit.
• Purexa™: Proprietary, high-capacity membrane chromatography products engineered for the rapid, high-yield purification of pDNA, mRNA, and mAbs, offering massive, measurable productivity and speed advantages over traditional, slower resin-based purification technologies.

Geographical Presence

The organization aggressively manages a highly optimized, global region-for-region manufacturing and localized distribution footprint. Commercial and industrial operations span across more than 150 administrative and technical locations worldwide, deliberately structured to efficiently serve localized heavy market demands and severely mitigate cross-border supply chain risks and tariff exposures.

United States and Canada

Revenue: $1,632.3 million | % of Total Revenue: 44.2%

This mature region serves as the core foundational revenue market, technological hub, and global corporate headquarters for the massive enterprise.

• Infrastructure: The region efficiently operates 20 specialized, high-capacity manufacturing plants and 5 massive distribution centers.
• Strategic Moves: In October 2024, the enterprise significantly strengthened this specific geography by aggressively opening a major new automated distribution center in Olive Branch, Mississippi, specifically targeted at exclusively supporting the high-margin, rapidly growing aftermarket sector.
• Physical Assets: The net carrying value of property, plant, and equipment within this specific region totals a massive $225.7 million.

Europe, Middle East, and Africa

Revenue: $1,027.2 million | % of Total Revenue: 27.8%

This highly complex region represents a highly sophisticated, deeply industrial market requiring strict environmental regulatory compliance and highly advanced technical product specifications.

• Infrastructure: The enterprise efficiently operates 16 highly specialized manufacturing plants and 2 primary, high-volume distribution centers specifically within this region.
• Strategic Moves: The company aggressively and successfully expanded its technical food and beverage filtration services across France, Germany, and Austria, successfully setting the operational stage for wider, lucrative market share gains across the entire European continent.
• Physical Assets: The net carrying value of property, plant, and equipment strictly in this region totals $195.2 million.

Asia Pacific

Revenue: $635.7 million | % of Total Revenue: 17.2%

This massive, highly populated region is a critical, long-term growth vector, directly supporting heavy rapid industrialization, massive continuous mining operations, and rapid, state-sponsored infrastructure development.

• Infrastructure: The expansive region is heavily supported by 11 dense manufacturing plants and 10 localized distribution centers, reflecting a dense, highly complex logistical network absolutely necessary for navigating the vast, segmented geography.
• Physical Assets: The net carrying value of property, plant, and equipment within this specific region totals $76.2 million.

Latin America

Revenue: $395.7 million | % of Total Revenue: 10.8%

This commodity-driven region primarily supports massive, continental-scale agricultural and deep-earth mining sectors that are absolutely reliant on the company’s heavy-duty, extreme-environment mobile solutions.

• Infrastructure: Operations in this rugged territory are strictly sustained by 7 ruggedized manufacturing plants and 6 localized distribution centers.
• Physical Assets: The net carrying value of property, plant, and equipment in this region totals $147.4 million, representing a highly significant capital investment relative to its current top-line revenue share, indicating long-term strategic positioning.

Profit and Loss

The enterprise delivered record financial performance in fiscal 2025, successfully and profitably navigating a highly turbulent macroeconomic environment, massive supply chain inflationary pressures, and a challenging cyclical backdrop through highly disciplined execution and strict global expense management.

Profit and Loss Metric (in millions)	Fiscal 2025	Fiscal 2024	Change ($)
Net Sales	$3,690.9	$3,586.3	$104.6
Cost of Sales	$2,404.7	$2,311.9	$92.8
Gross Profit	$1,286.2	$1,274.4	$11.8
Gross Margin (%)	34.8%	35.5%	-0.7%
Selling, General & Administrative	$641.0	$636.7	$4.3
Loss on Impairment of Assets	$62.0	$0.0	$62.0
Research & Development	$87.8	$93.6	-$5.8
Operating Income	$495.4	$544.1	-$48.7
Operating Margin (%)	13.4%	15.2%	-1.8%
Interest Expense	$24.2	$21.4	$2.8
Other Income, net	$(21.0)	$(12.6)	-$8.4
Earnings Before Income Taxes	$492.2	$535.3	-$43.1
Income Taxes	$125.2	$121.3	$3.9
Net Earnings	$367.0	$414.0	-$47.0
Net Earnings per Share – Diluted	$3.05	$3.38	-$0.33

• Revenue Growth Drivers: Total net sales increased by 2.9%, fundamentally and organically driven by a $60.0 million positive impact from raw sales volume expansion and a highly strategic $36.3 million benefit from disciplined pricing actions implemented globally.
• Margin Pressures: The consolidated gross margin experienced a decrease to 34.8%. This compression was primarily and directly caused by higher initial manufacturing costs associated with global footprint optimization initiatives, plant moves, and severe tariff-related inflation severely impacting raw material inventory valuations.
• Impairment Charge: A highly substantial, non-cash impairment charge of $62.0 million was strictly recorded during the fiscal year. This massive write-down heavily and directly reflected lower-than-anticipated bioprocessing capital spending in the broader market, severely affecting the near-term valuation of the previously acquired Univercells Technologies and Solaris operating units.
• Effective Tax Rate: The global effective tax rate mathematically rose to 25.4% from 22.7%. This notable increase was significantly and directly impacted by the specific discrete tax effect strictly related to the impairment of intangible assets in the Life Sciences segment.

Balance Sheet

The corporate balance sheet remains fundamentally and highly resilient, easily supporting highly aggressive capital returns to the global shareholder base while simultaneously funding continuous, massive strategic investments in long-term manufacturing capacity.

Balance Sheet Metric (in millions)	July 31, 2025	July 31, 2024
Cash and Cash Equivalents	$180.4	$232.7
Accounts Receivable, net	$662.2	$629.7
Inventories, net	$513.6	$476.7
Total Current Assets	$1,461.7	$1,438.1
Property, Plant and Equipment, net	$644.5	$645.5
Goodwill	$493.6	$478.4
Intangible Assets, net	$97.4	$171.9
Total Assets	$2,977.2	$2,914.3
Short-Term Borrowings	$31.2	$28.3
Accounts Payable	$368.6	$379.4
Total Current Liabilities	$757.2	$782.5
Long-Term Debt	$630.4	$483.4
Total Liabilities	$1,425.2	$1,523.7
Total Stockholders’ Equity	$1,453.5	$1,489.1

• Working Capital Dynamics: The overall net cash conversion cycle technically increased to 85 days from 76 days. This operational shift was heavily influenced by a strategic 4-day increase in days inventory outstanding, rising to 75 days to protect against supply shocks, and a 5-day decrease in days payable outstanding, dropping to 52 days.
• Debt Profile: Total consolidated debt strictly represents 31.5% of total capitalization, marking a calculated increase from 26.5% in the prior fiscal year. This higher leverage was primarily and deliberately driven by external financing required to fund the highly strategic equity method investment in Medica.
• Credit Facility Expansion: To aggressively secure future liquidity, the enterprise proactively and successfully amended its unsecured revolving credit facility. The strategic amendment extended the final maturity completely to 2030, massively increased the total borrowing limit to $600.0 million, and strategically added a completely new $200.0 million term loan facility.

Cash Flow

Robust, highly predictable free cash flow generation remains a massive, foundational strength of the enterprise. This continuous cash engine allows the organization to completely self-fund global operations while heavily and consistently rewarding shareholders through direct capital distribution.

Cash Flow Metric (in millions)	Fiscal 2025	Fiscal 2024	Change ($)
Net Cash Provided by Operating Activities	$418.8	$492.5	-$73.7
Net Cash Used in Investing Activities	$(150.4)	$(86.9)	-$63.5
Net Cash Used in Financing Activities	$(321.7)	$(355.9)	$34.2
Effect of Exchange Rate Changes	$1.0	$(4.1)	$5.1
Net (Decrease) Increase in Cash	$(52.3)	$45.6	-$97.9

• Operating Contraction: Overall operating cash flow mathematically decreased strictly due to intentionally higher working capital requirements necessary to aggressively support forward volume growth and the specific, highly localized timing of international income tax-related payments to various governments.
• Investing Accelerant: The highly notable increase in global investing cash outflows was directly and almost entirely tied to the highly strategic, long-term $71.2 million equity method investment deployed to secure a stake in Medica.
• Financing Returns: The company aggressively utilized its massive cash reserves deeply for direct shareholder returns. Management decisively directed a massive $331.5 million toward aggressive, open-market share repurchases and securely distributed $131.9 million strictly toward scheduled dividend payments during the fiscal year.

Board of Directors and Leadership Team

The massive global enterprise is securely guided by an incredibly experienced executive leadership team and overseen by a highly independent, extremely qualified Board of Directors composed of leading global industrial executives.

Executive Leadership Team

• Tod E. Carpenter (Chairman, President and Chief Executive Officer): Appointed as the ultimate Chief Executive in 2015 and elevated to Chairman of the Board in 2017. Carpenter originally joined the enterprise in 1996 and possesses an extensive, deep operational background, having previously served as Chief Operating Officer and successfully leading major global filtration divisions across the world.
• Bradley J. Pogalz (Chief Financial Officer): Officially appointed to the CFO position in November 2024. Pogalz strictly joined the finance team in 2015, previously and successfully serving as Vice President of Finance – Global FP&A and Director of Investor Relations, giving him deep knowledge of the corporate balance sheet.
• Amy C. Becker (Chief Legal Officer and Corporate Secretary): Appointed to the top legal role in November 2022. Becker has deep institutional knowledge, having originally joined the global organization in 1998, holding numerous high-level senior counsel positions dealing with complex international compliance and patent law.
• Guillermo Briseño (President, Industrial Solutions): Elevated to President in November 2022. Briseño has been highly active with the company since 2003, heavily and successfully driving highly profitable Latin American operations and global industrial sales strategies.
• Darcy D. DeVincke (Chief Human Resources Officer): Appointed to the executive suite in October 2024. DeVincke initially worked extensively at the company from 2001 to 2008, strategically returning in 2016 to successfully lead massive global HR initiatives strictly out of the European headquarters in Belgium.
• Richard B. Lewis (Chief Operating Officer): Officially appointed as COO in August 2025. Lewis joined the enterprise in 2002 and has successfully and profitably served as President of both the Life Sciences and Mobile Solutions segments, demonstrating vast, incredibly valuable cross-segment technical expertise.

Board of Directors

• Christopher M. Hilger: Serves as the crucial Lead Independent Director; currently the Chairman, President, and CEO of Securian Financial Group, Inc., providing massive financial oversight capabilities.
• Pilar Cruz: Currently serves as the Executive VP and Chief Sustainability Officer at the massive global agriculture firm Cargill, Inc., providing deep insights into agricultural end markets.
• Douglas A. Milroy: Former successful Chairman and CEO of G & K Services, Inc., bringing strong industrial service model experience to the boardroom.
• Willard D. Oberton: Retired Chairman of the massive industrial distributor Fastenal Company, providing critical insights into global supply chains and logistics.
• Richard M. Olson: Currently the Chairman, President, and CEO of The Toro Company, bringing massive, direct OEM perspective to the board.
• James J. Owens: Retired President and CEO of the major chemical firm H.B. Fuller Company, providing deep material science and manufacturing governance.
• Ajita G. Rajendra: Retired Executive Chairman of the heavy manufacturing firm A.O. Smith Corporation, adding deep global industrial manufacturing expertise.
• Trudy A. Rautio: Retired President and CEO of Carlson, bringing extensive global operational and executive governance experience.
• Jacinth C. Smiley: Currently the Executive VP and Chief Financial Officer of the massive global enterprise Hormel Foods, providing elite, modern financial reporting and audit oversight.

Subsidiaries, Associates, Joint Ventures

The massive enterprise utilizes highly targeted, legally complex joint ventures and strategic investments to massively amplify its global market reach, share technological risk, and dramatically increase localized manufacturing capabilities.

• Advanced Filtration Systems Inc. (50% Ownership): Established decades ago in 1986 as a highly strategic, incredibly successful joint venture heavily partnered with heavy-equipment giant Caterpillar Inc. This critical entity specializes strictly in designing and manufacturing highly profitable, high-efficiency fluid filters strictly utilized exclusively within Caterpillar’s massive worldwide machinery network. The specific entity generated highly lucrative equity earnings totaling exactly $12.9 million directly for the enterprise in fiscal 2025. Both massive parent companies strictly and equally guarantee certain debt and banking services for this critical joint venture.
• PT Panata Jaya Mandiri: A highly strategic, non-majority owned joint venture strictly accounted for under the complex equity method, explicitly designed to strategically and profitably support deep, localized market penetration in Southeast Asia.

Other Investments (Including Minority / Portfolio Holdings)

The enterprise executes a highly precise, heavily vetted acquisition and investment strategy, specifically and aggressively targeted at acquiring disruptive, highly advanced capabilities strictly within the rapidly expanding bioprocessing and medical device technological arenas.

• Medica S.p.A. (49% Ownership): In a massive strategic move executed in August 2024, the enterprise heavily invested exactly €62.1 million (translating to $67.9 million) to acquire a highly strategic 49% non-controlling equity stake in this Italy-based, high-tech leader in complex hollow fiber membrane filtration technology strictly designed for medical and water purification applications. Crucially, the enterprise holds a legally binding, exclusive option to completely acquire the remaining 51% stake strictly within a three-year window.
• Isolere Bio, Inc. (100% Ownership): Completely acquired in fiscal 2023, this Durham, North Carolina-based early-stage biotechnology firm developed the novel, incredibly valuable IsoTag™ reagents, designed specifically and exclusively to substantially improve product purity and drastically reduce manufacturing speed for advanced viral vectors.
• Univercells Technologies (100% Ownership): Completely acquired in fiscal 2023 and headquartered in highly regulated Belgium, this high-tech firm produces highly innovative biomanufacturing solutions, explicitly including the patented scale-X™ bioreactor and the highly complex NevoLine™ Upstream automated platform.
• Solaris Biotechnology S.r.l. (100% Ownership): Completely acquired in fiscal 2022 and strictly based in Italy, Solaris highly custom-designs and physically manufactures incredibly complex bioprocessing equipment, completely including advanced, multi-stage bioreactors and highly technical tangential flow filtration systems.
• Purilogics LLC (100% Ownership): Completely acquired in fiscal 2022, this highly innovative South Carolina-based biotechnology firm successfully developed the completely proprietary Purexa™ membrane chromatography platform, presenting massive, highly disruptive competitive advantages over traditional, slower resin technologies.

Physical Properties

The physical, hard-asset infrastructure of the enterprise is incredibly vast, highly modernized, heavily automated, and strategically, globally distributed across six distinct continents to ensure absolute maximum supply chain resilience against geopolitical shocks.

• Global Count: The entire physical footprint massively exceeds 150 total administrative, commercial, and technical locations worldwide.
• Manufacturing and Distribution: Exactly 77 distinct, massive locations operate specifically and exclusively as high-capacity manufacturing plants and/or heavily automated, high-volume distribution centers.
• Corporate Hubs: The massive primary corporate headquarters and highly restricted, central material science research facilities are deeply rooted in Minneapolis, Minnesota. Additional heavy administrative, complex engineering, and localized research nodes are highly strategically positioned across the European, Asian, and Latin American regions.
• Asset Valuation: The strictly audited net carrying value of physical property, massive plant structures, and heavy equipment stands at a massive $644.5 million, heavily and completely concentrated specifically in heavy industrial machinery and precision automated equipment, which boasts a gross valuation of exactly $1,118.6 million.

Founders

The massive industrial enterprise was officially and legally founded in the year 1915. While the foundational year is heavily and repeatedly documented within legally binding corporate filings, specific, granular biographical details of the original founding individuals are strictly not explicitly detailed within the provided financial framework or annual reports. The century-long, highly successful corporate legacy is fundamentally characterized by an absolutely unbroken, institutional focus on highly advanced, technology-led industrial filtration solutions.

Parent

The legally publicly traded entity operates entirely as the ultimate corporate parent corporation. It is continuously and publicly traded strictly on the massive New York Stock Exchange and directly, legally oversees all global operations, wholly owned subsidiaries, complex joint ventures, and strategic equity investments directly from the corporate suite.

Investments and Capital Expenditure Plans

Massive capital allocation is strictly and highly disciplined by the executive team, perfectly balancing highly aggressive, massive shareholder cash returns with absolutely essential, heavy funding for long-term technological dominance and massive global operational manufacturing efficiency.

• Capital Expenditures: The enterprise aggressively and successfully deployed exactly $77 million in heavy capital expenditures directly during fiscal 2025. These massive, long-term physical investments heavily and directly supported complex global projects specifically involving advanced solvent recovery systems, entirely new disk drive manufacturing technologies, and massive structural capacity for advanced air and alternative fuels filtration media. Executive management explicitly expects fiscal 2026 heavy capital expenditures to massively range strictly between $65 million and $85 million.
• Research & Development: The highly technical organization heavily invested a massive $87.8 million entirely in R&D directly during the fiscal year. This massive pool of capital strictly and exclusively supports deep scientific laboratory research, advanced facility testing costs, and the relentless, continuous development of breakthrough, patented material science capabilities.
• Future M&A Strategy: The executive enterprise strictly maintains a highly focused, aggressive strategy to massively accelerate long-term top-line growth strictly through targeted acquisitions in extremely high-margin technical areas, specifically and aggressively aiming to deeply penetrate massively underserved industrial service markets and completely acquire highly disruptive, early-stage bioprocessing technologies.

Shareholding Pattern

The massive corporate enterprise highly actively and aggressively manages its legal equity structure, strictly prioritizing massive, continuous capital returns entirely to its vast global shareholder base strictly through highly consistent cash dividends and highly aggressive, open-market stock repurchases.

• Shares Outstanding: Strictly as of the legally recorded date of September 12, 2025, there were exactly 115,907,357 legal shares of common stock publicly outstanding in the market.
• Registered Stockholders: The public company strictly reported exactly 1,065 legally registered stockholders of record directly as of September 2025.
• Share Repurchase Execution: Directly during fiscal 2025, the corporate treasury aggressively and successfully repurchased exactly 4.9 million shares from the open market, successfully returning a massive $333.6 million in raw cash directly to shareholders.
• Repurchase Authorization: The highly independent Board of Directors formally and legally authorized a massive, aggressive 12.0 million share repurchase plan specifically in November 2023, of which a massive 5.9 million shares legally remain fully available for future, aggressive open-market acquisition.

Future Strategy

The strictly defined strategic corporate roadmap is sharply and aggressively defined by three primary, massive growth pillars explicitly designed to continuously and aggressively expand the total addressable market and heavily leverage foundational, highly patented technological capabilities.

• Extend Market Access: The global enterprise is aggressively and massively growing its commercial presence in the highly technical bioprocessing markets organically and strictly through highly targeted, high-value acquisitions. Simultaneously, it is massively strengthening its engineering position in alternative power solutions completely through highly differentiated, patented product innovation.
• Expand Technologies and Solutions: The global company is aggressively and globally implementing a massive “Create-Connect-Replace-Service” business model. This highly lucrative strategy strictly involves massively expanding highly technical connected digital service offerings—such as aggressively increasing connected cellular industrial machines by over 50% strictly within this year—to successfully capture massive, highly lucrative, and sticky recurring aftermarket service share.
• Pursue Strategic Acquisitions: Executive management is highly actively, aggressively seeking to massively accelerate long-term growth by strictly acquiring specialized firms heavily armed with highly disruptive technologies in the bioprocessing space and massively expanding localized industrial service footprints deeply into highly underserved, high-growth global markets.

Key Strengths

The massive, highly defensive competitive economic moat of the global enterprise is heavily built upon a deeply entrenched foundation of vastly superior material science technology, a highly complex and deeply integrated global logistical network, and a remarkably resilient, highly defensive financial business model.

• The Razor-to-Razorblade Model: The core financial architectural structure heavily and fundamentally relies on generating massive, highly predictable recurring aftermarket replacement sales. Specifically within the massive Mobile Solutions segment alone, critical aftermarket replacement revenue structurally constitutes exactly 79% of total segment sales, effectively and massively insulating the entire corporate company from the severe, destructive cyclicality of new heavy equipment manufacturing recessions.
• Technological Superiority: The advanced enterprise strictly owns and fiercely defends a formidable, massive legal portfolio of over 3,100 global patents. Strictly proprietary media strictly like PowerCore®, Ultra-Web®, and Alpha-Web™ consistently provide massive, highly measurable, and completely undeniable performance advantages that rival competitors severely struggle to legally replicate, strictly allowing for massive, dominant premium pricing power in the market.
• Global Diversification: By strictly maintaining a highly complex, vastly diversified physical presence strictly across distinct, completely separate global geographies and vastly different, uncorrelated end markets, the corporate company successfully and consistently neutralizes highly localized, severe economic recessions.

Key Challenges and Risks

Operating a massively complex, heavy high-technology manufacturing enterprise completely on a vast global scale inherently and unavoidably involves navigating severe, completely unpredictable, and constantly evolving massive macroeconomic risks.

• Macroeconomic and Geopolitical Instability: The massive, highly exposed global footprint directly exposes the entire enterprise to the massive global rise of extreme nationalism, highly disruptive protectionist trade policies, and severe, highly punitive global tariff actions. The company strictly and explicitly notes in legal filings that sustained, massive tariff increases completely from China, Mexico, or the EU could dramatically, severely, and highly adversely impact its complex, highly integrated global supply chain and raw profitability.
• Disruptive Technological Shifts: The massive, rapid global electrification of all commercial vehicles and the aggressive regulatory transition toward alternative power solutions present an absolute, massive existential threat completely to traditional, highly profitable diesel engine filtration products. Complete operational failure to successfully adapt to these highly disruptive green innovations could massively and rapidly completely displace existing, massive legacy revenue streams.
• Supply Chain and Material Costs: Heavy global operations are completely, unavoidably reliant strictly on massive quantities of global steel, highly specialized synthetic filter media, and volatile petrochemical-based plastic products. The massive company often dangerously concentrates specific material sourcing strictly from limited, highly specialized global suppliers; any severe disruption or massive, unexpected inflationary spike completely in these raw commodity materials could severely and immediately massively compress gross corporate margins.
• M&A Execution Risks: While massive strategic acquisitions are a strict core growth strategy, successfully integrating highly complex, entirely culturally different biotechnology firms poses immense, incredibly dangerous operational challenges. This exact massive risk violently materialized strictly in fiscal 2025, completely forcing a massive, incredibly painful $62.0 million non-cash impairment charge strictly due to slower-than-anticipated bioprocessing timelines.
• Cybersecurity Vulnerabilities: The massive, digitally connected enterprise strictly collects and heavily stores highly sensitive, massively valuable intellectual property and highly proprietary technical data entirely across complex global digital networks. A highly successful, massive cyberattack could severely result completely in the absolute destruction of proprietary data, massively defective automated manufacturing, massive and costly operational factory downtimes, and severe, deeply punitive legal and regulatory penalties.

Conclusion and Strategic Outlook

Donaldson Company, Inc. strongly concludes the highly volatile fiscal 2025 strictly from a massive position of profound, highly structural financial and operational strength, having highly successfully generated massive, record total sales of $3.69 billion and highly impressive, record adjusted operating margins strictly despite navigating a deeply turbulent, highly inflationary global macroeconomic environment. The massive executive enterprise has completely masterfully leveraged its highly defensive, core “razor-to-sell-razorblade” aftermarket model to massively drive incredible recurring revenue completely through its vast aftermarket global channels, completely and successfully insulating the massive corporate balance sheet completely from the severe, destructive cyclicality of its large OEM manufacturing partners.

Looking completely forward, the deeply planned strategic outlook is highly aggressively focused strictly on advanced technological evolution and massive global market expansion. While the massive, painful $62.0 million accounting impairment charge deeply within the advanced Life Sciences segment strictly highlights the massive inherent risks of aggressively acquiring early-stage, highly complex bioprocessing technologies, the massive company’s continuous, heavy capital investments strictly in breakthrough, next-generation solutions like the highly advanced IsoTag™ reagents and Purexa™ membrane chromatography deeply demonstrate a completely clear, undeniable commitment strictly to completely dominating the massively high-margin, ultra-high-growth biological sectors of the absolute future. Strictly supported by a massive, highly defensive fortress balance sheet, a newly massively expanded $600 million corporate credit facility, and a relentless, legally binding commitment strictly to massive shareholder capital returns entirely via highly aggressive stock repurchases, the massive global enterprise is highly optimized strictly to massively advance complex filtration technologies completely for a fundamentally cleaner, massively more efficient global economy.

FAQ Section

What is the core business model of the enterprise? The massive enterprise fundamentally and highly successfully operates strictly on a highly lucrative “razor-to-sell-razorblade” business model. It strictly partners directly with massive OEMs to explicitly integrate its advanced, highly proprietary filtration systems completely into entirely new capital equipment, which subsequently and highly predictably drives massive decades of highly lucrative, completely recurring revenue completely through the continuous sale of highly specialized replacement filters and massive maintenance services.

How much did the company generate in revenue for fiscal 2025? The massive global organization successfully achieved an incredible, all-time record high of exactly $3,690.9 million strictly in total consolidated net sales strictly for the fiscal year 2025, heavily driven by a massive $60.0 million core volume increase and a highly strategic, highly profitable $36.3 million direct benefit completely from strict, highly disciplined global pricing actions.

Why did the company record a massive $62 million impairment charge? Directly during the highly challenging third quarter of fiscal 2025, the massive enterprise strictly recorded a massive $62.0 million non-cash accounting impairment charge strictly and entirely related to its recently acquired bioprocessing businesses. This was fundamentally, completely driven strictly by severely lower-than-anticipated global capital spending strictly in the broader, macro bioprocessing market and highly extended, severe drug development regulatory timelines severely affecting the internal valuation of the Univercells Technologies and Solaris units.

What geographic region generates the most global revenue? The massive, highly mature United States and Canada region is strictly the absolute largest corporate market, massively generating exactly $1,632.3 million, which completely and mathematically accounts strictly for a massive 44.2% of the total consolidated global net sales.

How is the company returning massive capital directly to shareholders? The massive enterprise strictly executes an incredibly aggressive, highly disciplined capital return program. Strictly in fiscal 2025 alone, it successfully and completely returned a massive $465 million directly to shareholders, completely combining a massive $331.5 million entirely in open-market share repurchases and strictly distributing exactly $131.9 million completely in direct cash dividend payments. Furthermore, the massive company has highly successfully, consistently mathematically increased its strict cash dividend entirely for 30 consecutive, unbroken years.

What massive technological threat do electric vehicles specifically pose to the corporate company? The massive, highly accelerated wider global regulatory adoption of advanced technologies providing zero-emission alternatives completely to traditional, legacy diesel engines, strictly such as massive heavy-equipment electrification, absolutely poses a direct, massive disruptive technological threat. This massive, fundamental technological shift could severely reduce or completely, permanently eliminate the global demand entirely for legacy heavy fuel, extreme lube, and traditional emission filtration products.

Official Site: donaldson.com

Source: Content on FirmsWorld.com is based on publicly available corporate filings, regulatory disclosures, annual reports, SEC 10-K filings, investor relations materials, and, where applicable, direct communications with the company.